Tuesday, July 14

    Registration Open and Networking Breakfast

    WELCOME AND OPENING REMARKS

    Setting the Stage for the Day with an Overview of the Most Important Trends, Breakthroughs, and Opportunities Shaping the Future of Retinal Innovation

    Firas M. Rahhal, MD, Partner, Retina Vitreous Associates Medical Group; General Partner, ExSight Ventures, LLC , Partner , Retina Vitreous Associates Medical Grp

    INNOVATION SHOWCASE 1

    FROM EVIDENCE TO EXIT: HOW RETINAL INNOVATION GETS BUILT, FUNDED, AND BROUGHT TO MARKET

    Panel Moderator:

    PANEL DISCUSSION:
    Leaders across the Innovation Ecosystem Discuss How Retinal Technologies Move from Early Discovery through Clinical Development, Financing, Partnerships, and Successful Exits

    John Pollack, MD, Partner, EyeSci Angels; Partner, Illinois Retina Associates , Partner , EyeSci Angels

    Panelists:

    Mayssa Attar, PhD, Sr VP Pharmaceutical & Consumer R & D Head, Pharma & Consumer R&D, Bausch + Lomb Inc , Sr VP Pharmaceutical & Consumer R & D Head , Pharma & Consumer R&D , Bausch + Lomb Inc

    Eugene de Juan Jr, MD, Clinical Prof, Ophthalmology, Univ of California San Francisco , Clinical Prof , Ophthalmology , Univ of California San Francisco

    David A Esposito, CEO, ONL Therapeutics Inc , CEO , ONL Therapeutics Inc

    Firas M. Rahhal, MD, Partner, Retina Vitreous Associates Medical Group; General Partner, ExSight Ventures, LLC , Partner , Retina Vitreous Associates Medical Grp

    Kuldev Singh, MD, MPH, Professor, Ophthalmology, Stanford University , Prof , Ophthalmology , Stanford Univ

    Networking Coffee Break

    DURABLE THERAPIES IN RETINA SPOTLIGHT: EXTENDING TREATMENT BEYOND MONTHLY INJECTIONS

    THE END OF MONTHLY VEG-F: HYPE OR REALITY?

    THE GA DECISION POINT: TREAT EARLIER OR WAIT?

    Panel Moderator:

    PANEL DISCUSSION:
    Examining whether advances in drug delivery and long-acting therapies can finally move retina care beyond monthly injections.

    Baruch D Kuppermann, MD, PhD, Professor & Chair, Ophthalmology, University of California Irvine , Prof & Chair , Ophthalmology , Univ of California Irvine

    Panelists:

    Thomas A Ciulla, MD. MBA, President & CEO, ikarovec, Adjunct Clinical Professor of Ophthalmology, Indiana University Vitreoretinal Medicine and Surgery, Midwest Eye Institute , President & CEO , ikarovec

    Emmett T Cunningham, Jr. MD, PhD, MPH, Executive Chairman, Eyconis / Senior Advisor, HealthQuest Captial Mgmt , Sr Advisor , Eyeconis HealthQuest Captial Mgmt , HealthQuest Capital

    Dilsher S Dhoot, MD, Vitreoretinal Surgeon, California Retina Consultants , Vitreoretinal Surgeon , California Retina Consultants

    Shamika Gune, MD, Grp Medical Dir, Genentech Inc , Grp Medical Dir , Genentech Inc

    Panel Moderator:

    PANEL DISCUSSION:
    Examining the evidence behind earlier intervention in geographic atrophy and its potential impact on long-term visual outcomes.

    Andrew A Moshfeghi, MD, MBA, Associate Professor, Clinical Ophthalmology, University of Southern California , Vice Chair , Clinical Ophthalmology , Univ of Southern California Roski Eye Institute

    Panelists:

    Jay Chhablani, MD, Vice Chair, Clinical Trials; Director, Professor of Ophthalmology, UPMC Vision Institute , Vice Chair, Clinical Trials; Director, Professor of Ophthalmology , UPMC Vision Institute

    Carlos Quezada-Ruiz, MD, FASRS, Assistant Professor of Ophthalmology, Retina and Vitreous, Instituto de Oftalmologia Fundacion Conde de Valenciana IAP , Assistant Professor of Ophthalmology , Retina and Vitreous , Instituto de Oftalmologia Fundacion Conde de Valenciana IAP

    Michael A Singer, MD, Clinical Professor, Ophthalmology, University of Texas San Antonio , Clinical Prof , Ophthalmology , Univ of Texas San Antonio

    Nadia K Waheed, MD, Professor, Ophthalmology, New England Eye Center , Prof , Ophthalmology , New England Eye Ctr

    AI, IMAGING, AND PRECISION INTERVENTION: THE DIGITAL TRANSFORMATION OF RETINA

    Networking Luncheon

    REGENERATIVE APPROACHES IN RETINAL DISEASE: FROM GENETIC REPAIR TO FUNCTIONAL RESTORATION

    INNOVATION SHOWCASE 2

    Networking Refreshment Break

    VIEW FROM ASRS

    Panel Moderator:

    PANEL DISCUSSION:
    Leadership from the American Society of Retina Specialists Shares Frontline Perspectives on Emerging Clinical Trends, Innovation Adoption, and the Evolving Needs of Retina Physicians

    Gaurav K. Shah, MD, Retina Surgeon, West Coast Retina Medical Group; Chair, California Pacific Medical Center , Retina Surgeon , West Coast Retina Medical Group

    Panelists:

    Jill Blim, CEO, American Society of Retina Specialists , CEO , American Society of Retina Specialists

    Geoffrey Emerson, MD, PhD, FASRS, Retina Consultants of Minnesota, President, ASRS , President , American Society of Retina Specialists

    J Michael Jumper, MD, Chief, West Coast Retina Medical Grp , Chief , West Coast Retina Medical Grp

    Christina Y Weng, MD, MBA, Prof & AR McPherson Retina Rsrch Foundation Chair, Ophthalmology, Baylor College of Medicine , Prof & AR McPherson Retina Rsrch Foundation Chair , Ophthalmology , Baylor College of Medicine

    Charles C Wykoff, MD, PhD, Vitreoretinal Specialist, Surgical & Medical, Retina Consultants of Texas , Vitreoretinal Specialist , Surgical & Medical , Retina Consultants of Texas

    THE IMPACT OF RECENT FDA GUIDANCE ON DRUG DEVELOPMENT

    Panel Moderator:

    PANEL DISCUSSION:
    Navigating Regulatory Risk, Fundraising and Investment Decisions

    Pravin U. Dugel, MD, Executive Chairman, President, and CEO, Ocular Therapeutix, Inc. , Executive Chairman, President, and CEO , Ocular Therapeutix, Inc.

    Panelists:

    Arthur A. Ciociola, Chief Regulatory & Quality Officer, Ocular Therapeutix Inc. , Chief Regulatory & Quality Officer , Ocular Therapeutix Inc

    Anupam Dalal, MD, MBA, Chief Investment Officer & Managing Member, Acuta Capital Partners LLC , Chief Investment Officer & Managing Member , Acuta Capital Partners LLC

    Adrienne Graves, PhD, Independent Director, Public and Private Biotech/Pharma Companies - Board Chair, RD Fund - Former CEO, Santen Inc - Former Chair, Iveric Bio , Board of Directors , Glaucoma 360 , Ocular Therapeutix, Opus Genetics, Harrow

    Rael Mazansky, MD, Managing Director, Deep Track Capital , Managing Director , Deep Track Capital

    Snehal Shah, PharmD, President, Research & Development, Oculis , President , R&D , Oculis

    Kuldev Singh, MD, MPH, Professor, Ophthalmology, Stanford University , Prof , Ophthalmology , Stanford Univ

    REVERSE PITCH

    Panel Moderator:

    PANEL DISCUSSION:
    Business Development Leaders Present Strategic Priorities and Partnership Needs, Offering Innovators Insight into What Major Companies Are Actively Seeking

    Firas M. Rahhal, MD, Partner, Retina Vitreous Associates Medical Group; General Partner, ExSight Ventures, LLC , Partner , Retina Vitreous Associates Medical Grp

    Panelists:

    Fabio Baschiera, Head Global Clinical Dev Eye Health, Boehringer Ingelheim Intl GmbH , Head Global Clinical Dev Eye Health , Boehringer Ingelheim Intl GmbH

    Wayne Caulder, VP & GM, Bausch + Lomb Inc , VP & GM , Bausch + Lomb Inc

    Douglas E Faunce, PhD, Exec Dir & Head Search & Evaluation, AbbVie Ventures, AbbVie Inc , Exec Dir & Head Search & Evaluation , AbbVie Ventures , AbbVie Inc

    Tomas Navratil, PhD, Chief Dev Officer, R&D, Glaukos Corp , Chief Development Officer , R&D , Glaukos Corp

    Networking Reception

    Close of Summit